KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Halozyme Therapeutics (HALO) Gross Profit: 2009-2025

Historic Gross Profit for Halozyme Therapeutics (HALO) over the last 17 years, with Sep 2025 value amounting to $299.0 million.

  • Halozyme Therapeutics' Gross Profit rose 24.25% to $299.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 35.12%. This contributed to the annual value of $855.9 million for FY2024, which is 34.39% up from last year.
  • Per Halozyme Therapeutics' latest filing, its Gross Profit stood at $299.0 million for Q3 2025, which was up 7.04% from $279.4 million recorded in Q2 2025.
  • Over the past 5 years, Halozyme Therapeutics' Gross Profit peaked at $299.0 million during Q3 2025, and registered a low of $70.8 million during Q1 2021.
  • Over the past 3 years, Halozyme Therapeutics' median Gross Profit value was $191.7 million (recorded in 2024), while the average stood at $208.0 million.
  • Examining YoY changes over the last 5 years, Halozyme Therapeutics' Gross Profit showed a top increase of 261.85% in 2021 and a maximum decrease of 15.73% in 2021.
  • Over the past 5 years, Halozyme Therapeutics' Gross Profit (Quarterly) stood at $80.4 million in 2021, then spiked by 73.32% to $139.4 million in 2022, then climbed by 27.53% to $177.7 million in 2023, then skyrocketed by 44.00% to $256.0 million in 2024, then grew by 24.25% to $299.0 million in 2025.
  • Its Gross Profit was $299.0 million in Q3 2025, compared to $279.4 million in Q2 2025 and $216.5 million in Q1 2025.